Location
United States, North America
Check Size
$1M - $75M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health & Hospital Services
Pharmaceuticals
Medical Devices
About Investor
Carl L. Gordon is a Managing Partner at OrbiMed, a New York City–based global healthcare investment firm. His investments range from $1M to $75.0M, with a sweet spot around $4.0M, targeting pharmaceuticals, medical devices, and healthcare services at seed through Series B stages. He is one of the founding members of OrbiMed and has decades of experience investing in life sciences.
Previous investments
ENYO Pharma
43M |2024
47M |2018
BlossomHill Therapeutics
100M |2024
71M |2021
RayThera
110M |2025
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP